Shubha Chungi

Title: Innovator Spotlight: Shubha Chungi

Introduction

Shubha Chungi is an accomplished inventor based in Chestnut Hill, Massachusetts, known for his contributions to pharmaceutical formulations. With two patents to his name, he has made significant strides in the field of modified release medications.

Latest Patents

Chungi's latest patents focus on innovative milnacipran formulations. The first patent describes a modified release composition that facilitates delayed and extended release of milnacipran. This formulation includes milnacipran or a salt thereof, along with an extended release excipient and a delayed release excipient. Upon administration, it offers a time of float (Tof) of 4-10 hours, providing a noteworthy advancement in medication delivery.

Career Highlights

Currently, Shubha Chungi is employed at Collegium Pharmaceutical, Inc., where he utilizes his expertise in formulation development to create therapeutic solutions for patients. His dedication to improving drug delivery systems has positioned him as a notable figure in pharmaceutical innovation.

Collaborations

In his career, Chungi has collaborated with esteemed colleagues, including Jane C Hirsh and Roman V Rariy. These partnerships highlight his commitment to advancing pharmaceutical research and innovation while fostering a collaborative work environment.

Conclusion

Shubha Chungi's work in the realm of modified release compositions has established him as a prominent inventor in the pharmaceutical industry. His contributions continue to pave the way for improved patient outcomes through innovative drug formulations.